CMPS Return on Tangible Equity | COMPASS PATHWAYS PLC

COMPASS PATHWAYS PLC (CMPS) Return on Tangible Equity

2026-06-30: Return Tang Equity -466.31%.
2026-03-31: Return Tang Equity -54.73%.
2025-12-31: Return Tang Equity 544.70%.
2025-09-30: Return Tang Equity -631.31%.

Complete source-backed return tang equity history.

Available history: 2019-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-466.31%
2026-03-31	-54.73%
2025-12-31	544.70%
2025-09-30	-631.31%
2025-06-30	-84.96%
2025-03-31	-70.50%
2024-12-31	-100.28%
2024-09-30	-74.77%
2024-06-30	-61.52%
2024-03-31	-49.95%
2023-12-31	-52.48%
2023-09-30	-46.14%
2023-06-30	-61.20%
2023-03-31	-58.49%
2022-12-31	-50.48%
2022-09-30	-44.32%
2022-06-30	-37.27%
2022-03-31	-30.90%
2021-12-31	-25.22%
2021-09-30	-21.25%
2021-06-30	-19.82%
2021-03-31	-34.43%
2020-12-31	-30.92%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	544.70%
2024-12-31	-100.28%
2023-12-31	-52.48%
2022-12-31	-50.48%
2021-12-31	-25.22%
2020-12-31	-30.69%
2019-12-31	64.53%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ANI PHARMACEUTICALS INC (ANIP)	United States	$1.810B	18.77
Septerna, Inc. (SEPN)	United States	$1.783B	-63.01
Xencor Inc (XNCR)	United States	$1.776B	-7.33
Zymeworks Inc. (ZYME)	United States	$1.902B	-12.44
Eton Pharmaceuticals, Inc. (ETON)	United States	$1.701B	80.74
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)	United States	$1.962B	-5.38
Biohaven Ltd. (BHVN)	United States	$1.990B	-3.83
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82